42 related articles for article (PubMed ID: 1994494)
1. The effects of calcium and calcium channel blockade on peptide YY and neuropeptide Y release.
McFadden DW; Rudnicki M; Fischer JE
Surg Gynecol Obstet; 1991 Mar; 172(3):181-5. PubMed ID: 1994494
[TBL] [Abstract][Full Text] [Related]
2. Release of intraluminal and circulatory peptide YY after intravenous CCK-8 in conscious dogs.
Kuvshinoff BW; Rudnicki M; McFadden DW; Nussbaum MS; Fischer JE
Curr Surg; 1990; 47(5):338-40. PubMed ID: 2257750
[No Abstract] [Full Text] [Related]
3. Independent release of peptide YY (PYY) into the circulation and ileal lumen of the awake dog.
McFadden DW; Rudnicki M; Nussbaum MS; Balasubramaniam A; Fischer JE
J Surg Res; 1989 Apr; 46(4):380-5. PubMed ID: 2704235
[TBL] [Abstract][Full Text] [Related]
4. Effect of total jejunoileal denervation on fat-stimulated release of peptide YY and cholecystokinin.
Evers BM; Townsend CM; Uchida T; Greeley GH; Allen E; Thompson JC
Surgery; 1990 Aug; 108(2):248-52; discussion 252-3. PubMed ID: 2382224
[TBL] [Abstract][Full Text] [Related]
5. Abnormalities of fasting serum concentrations of peptide YY in the idiopathic inflammatory bowel diseases.
Koch TR; Roddy DR; Go VL
Am J Gastroenterol; 1987 Apr; 82(4):321-6. PubMed ID: 3565336
[TBL] [Abstract][Full Text] [Related]
6. Time-course of morphologic changes and peptide YY adaptation in ileal mucosa after loop ileostomy in humans.
Oh NG; Son GM; Sin JY; Ding XZ; Adrian TE
Dis Colon Rectum; 2005 Jun; 48(6):1287-94. PubMed ID: 15789123
[TBL] [Abstract][Full Text] [Related]
7. Peptide YY: a potential proabsorptive hormone for the treatment of malabsorptive disorders.
Liu CD; Aloia T; Adrian TE; Newton TR; Bilchik AJ; Zinner MJ; Ashley SW; McFadden DW
Am Surg; 1996 Mar; 62(3):232-6. PubMed ID: 8607584
[TBL] [Abstract][Full Text] [Related]
8. Extrinsic neural contribution to ileal peptide YY (PYY) release.
Rudnicki M; Kuvshinoff BW; McFadden DW
J Surg Res; 1992 Jun; 52(6):591-5. PubMed ID: 1528036
[TBL] [Abstract][Full Text] [Related]
9. Effects of glucose on circulating and ileal intraluminal peptide YY and pancreatic polypeptide release.
Rudnicki M; McFadden DW; Kuvshinoff BW; Dayal R; Fischer JE
Am J Surg; 1991 Sep; 162(3):268-70. PubMed ID: 1928591
[TBL] [Abstract][Full Text] [Related]
10. Effects of the neuropeptide Y Y2 receptor antagonist BIIE0246 on sympathetic transmitter release in the pig in vivo.
Malmström RE; Lundberg JN; Weitzberg E
Naunyn Schmiedebergs Arch Pharmacol; 2002 Feb; 365(2):106-11. PubMed ID: 11819028
[TBL] [Abstract][Full Text] [Related]
11. Sensitive radioimmunoassay for measurement of circulating peptide YY.
Chen MH; Balasubramanian A; Murphy RF; Tabata K; Fischer JE; Chen IW; Joffe SN
Gastroenterology; 1984 Dec; 87(6):1332-8. PubMed ID: 6548459
[TBL] [Abstract][Full Text] [Related]
12. [Y1 receptors mediate inhibitory and stimulatory effects of peptide YY in isolated small intestine and large intestine muscles of the rabbit].
Kölbel CB; Grandt D; Holtmann G; Schöler S; Reeve JR; Eysselein VE
Med Klin (Munich); 1993 Feb; 88 Suppl 1():9-14. PubMed ID: 8464401
[TBL] [Abstract][Full Text] [Related]
13. Peptide YY (3 -36) inhibits dopamine and norepinephrine release in the hypothalamus.
Brunetti L; Orlando G; Ferrante C; Chiavaroli A; Vacca M
Eur J Pharmacol; 2005 Sep; 519(1-2):48-51. PubMed ID: 16095590
[TBL] [Abstract][Full Text] [Related]
14. [Antisecretory effects of YY peptide and neuropeptide Y at three levels of the small intestine in rats].
Souli A; Fu-Cheng X; Chariot J; Tsocas A; Rozé C
Gastroenterol Clin Biol; 1996 Feb; 20(1):8-14. PubMed ID: 8734306
[TBL] [Abstract][Full Text] [Related]
15. Peptide YY(1-36) and peptide YY(3-36): Part II. Changes after gastrointestinal surgery and bariatric surgery.
Ballantyne GH
Obes Surg; 2006 Jun; 16(6):795-803. PubMed ID: 16756746
[TBL] [Abstract][Full Text] [Related]
16. Early regional expression and secretion of peptide YY and enteroglucagon after massive resection of small bowel.
Bilchik AJ; Hines OJ; Adrian TE; Skotzko MJ; McFadden DW; Zinner MJ; Ashley SW
J Am Coll Surg; 1995 Apr; 180(4):417-26. PubMed ID: 7719545
[TBL] [Abstract][Full Text] [Related]
17. Importance of the ileum in neurotensin released by fat.
Walker JP; Fujimura M; Sakamoto T; Greeley GH; Townsend CM; Thompson JC
Surgery; 1985 Aug; 98(2):224-9. PubMed ID: 4023920
[TBL] [Abstract][Full Text] [Related]
18. Neuropeptide Y as a partial agonist of the Y1 receptor.
Sah R; Balasubramaniam A; Parker MS; Sallee F; Parker SL
Eur J Pharmacol; 2005 Nov; 525(1-3):60-8. PubMed ID: 16293244
[TBL] [Abstract][Full Text] [Related]
19. Neuropeptide Y and peptide YY inhibit lipolysis in human and dog fat cells through a pertussis toxin-sensitive G protein.
Valet P; Berlan M; Beauville M; Crampes F; Montastruc JL; Lafontan M
J Clin Invest; 1990 Jan; 85(1):291-5. PubMed ID: 2104880
[TBL] [Abstract][Full Text] [Related]
20. Regional distribution and release of peptide YY with fatty acids of different chain length.
Aponte GW; Fink AS; Meyer JH; Tatemoto K; Taylor IL
Am J Physiol; 1985 Dec; 249(6 Pt 1):G745-50. PubMed ID: 3841263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
